Follow the people · Insider
Emily Luisa Hill
Emily Luisa Hill files insider transactions with the SEC as a chief financial officer of Replimune Group (REPL). We hold 3 disclosed purchases and sales filed since 3 June 2019, 2 of them in the last 90 days.
- Files forREPL
- Disclosed buys and sells3 in all, 2 in the last 90 days
- Last disclosure19 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 18 September 2023 — 17 August 2026Chief Financial Officer · Replimune Group (REPL)15 Form 4 lines · source: SEC Form 4
- Filed 31 May 2019 — 27 March 2023Chief Financial Officer · Ptc Therapeutics (PTCT)41 Form 4 lines · source: SEC Form 4
Everything they disclosed
56 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 9,256 shares of Replimune GroupSEC Form 419 August 2026Common Stock · traded 17 August 2026 · filed 19 August 2026
- ▼ sold on the open market 11,448 shares of Replimune GroupSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- ▼ sold on the open market 7,812 shares of Replimune GroupSEC Form 420 May 2026Common Stock · traded 18 May 2026 · filed 20 May 2026
- was granted 50,000 shares of Replimune GroupSEC Form 47 April 2026Common Stock · traded 1 April 2026 · filed 7 April 2026
- was granted 75,000 shares of Replimune Group (a derivative holding)SEC Form 47 April 2026Employee Stock Option (right to buy) · traded 1 April 2026 · filed 7 April 2026
- was granted 60,000 shares of Replimune GroupSEC Form 419 December 2025Common Stock · traded 19 December 2025 · filed 19 December 2025
- ▼ sold on the open market 9,154 shares of Replimune GroupSEC Form 419 August 2025Common Stock · traded 15 August 2025 · filed 19 August 2025
- ▼ sold on the open market 2,535 shares of Replimune GroupSEC Form 422 May 2025Common Stock · traded 20 May 2025 · filed 22 May 2025
- was granted 67,500 shares of Replimune Group (a derivative holding)SEC Form 43 April 2025Employee Stock Option (right to buy) · traded 1 April 2025 · filed 3 April 2025
- was granted 45,000 shares of Replimune GroupSEC Form 43 April 2025Common Stock · traded 1 April 2025 · filed 3 April 2025
- ▼ sold on the open market 8,938 shares of Replimune GroupSEC Form 419 August 2024Common Stock · traded 16 August 2024 · filed 19 August 2024
- was granted 80,000 shares of Replimune Group (a derivative holding)SEC Form 43 April 2024Employee Stock Option (right to buy) · traded 1 April 2024 · filed 3 April 2024
- was granted 26,665 shares of Replimune GroupSEC Form 43 April 2024Common Stock · traded 1 April 2024 · filed 3 April 2024
- was granted 125,000 shares of Replimune Group (a derivative holding)SEC Form 420 September 2023Employee Stock Option (right to buy) · traded 18 September 2023 · filed 20 September 2023
- was granted 83,330 shares of Replimune GroupSEC Form 420 September 2023Common Stock · traded 18 September 2023 · filed 20 September 2023
- ▼ sold on the open market 7,363 shares of Ptc TherapeuticsSEC Form 429 March 2023Common Stock · traded 27 March 2023 · filed 29 March 2023
- ▼ sold on the open market 575 shares of Ptc TherapeuticsSEC Form 42 February 2023Common Stock · traded 31 January 2023 · filed 2 February 2023
- ▼ sold on the open market 223 shares of Ptc TherapeuticsSEC Form 426 January 2023Common Stock · traded 24 January 2023 · filed 26 January 2023
- ▼ sold on the open market 497 shares of Ptc TherapeuticsSEC Form 412 January 2023Common Stock · traded 10 January 2023 · filed 12 January 2023
- ▼ sold on the open market 418 shares of Ptc TherapeuticsSEC Form 412 January 2023Common Stock · traded 11 January 2023 · filed 12 January 2023
- ▼ sold on the open market 758 shares of Ptc TherapeuticsSEC Form 411 January 2023Common Stock · traded 9 January 2023 · filed 11 January 2023
- was granted 42,500 shares of Ptc Therapeutics (a derivative holding)SEC Form 49 January 2023Stock Option (Right to Buy) · traded 5 January 2023 · filed 9 January 2023
- was granted 19,500 shares of Ptc TherapeuticsSEC Form 49 January 2023Common Stock · traded 5 January 2023 · filed 9 January 2023
- ▼ sold on the open market 7,910 shares of Ptc TherapeuticsSEC Form 41 April 2022Common Stock · traded 31 March 2022 · filed 1 April 2022
- ▼ sold on the open market 553 shares of Ptc TherapeuticsSEC Form 43 February 2022Common Stock · traded 1 February 2022 · filed 3 February 2022
- ▼ sold on the open market 211 shares of Ptc TherapeuticsSEC Form 427 January 2022Common Stock · traded 25 January 2022 · filed 27 January 2022
- was granted 58,500 shares of Ptc Therapeutics (a derivative holding)SEC Form 411 January 2022Stock Option (Right to Buy) · traded 7 January 2022 · filed 11 January 2022
- ▼ sold on the open market 800 shares of Ptc TherapeuticsSEC Form 411 January 2022Common Stock · traded 7 January 2022 · filed 11 January 2022
- was granted 15,600 shares of Ptc TherapeuticsSEC Form 411 January 2022Common Stock · traded 7 January 2022 · filed 11 January 2022
- ▼ sold on the open market 173 shares of Ptc TherapeuticsSEC Form 46 January 2022Common Stock · traded 4 January 2022 · filed 6 January 2022
- ▼ sold on the open market 541 shares of Ptc TherapeuticsSEC Form 42 February 2021Common Stock · traded 1 February 2021 · filed 2 February 2021
- ▼ sold on the open market 275 shares of Ptc TherapeuticsSEC Form 427 January 2021Common Stock · traded 25 January 2021 · filed 27 January 2021
- exercised options over 2,430 shares of PTCT (a derivative holding)SEC Form 412 January 2021Stock Option (Right To Buy) · traded 8 January 2021 · filed 12 January 2021
- exercised options over 3,825 shares of PTCT (a derivative holding)SEC Form 412 January 2021Stock Option (Right To Buy) · traded 8 January 2021 · filed 12 January 2021
- exercised options over 10,500 shares of PTCT (a derivative holding)SEC Form 412 January 2021Stock Option (Right To Buy) · traded 8 January 2021 · filed 12 January 2021
- exercised options over 9,278 shares of PTCT (a derivative holding)SEC Form 412 January 2021Stock Option (Right To Buy) · traded 8 January 2021 · filed 12 January 2021
- exercised options over 2,430 shares of PTCTSEC Form 412 January 2021Common Stock · traded 8 January 2021 · filed 12 January 2021
- ▼ sold on the open market 2,430 shares of PTCTSEC Form 412 January 2021Common Stock · traded 8 January 2021 · filed 12 January 2021
- exercised options over 3,825 shares of PTCTSEC Form 412 January 2021Common Stock · traded 8 January 2021 · filed 12 January 2021
- ▼ sold on the open market 3,825 shares of PTCTSEC Form 412 January 2021Common Stock · traded 8 January 2021 · filed 12 January 2021
- exercised options over 10,500 shares of PTCTSEC Form 412 January 2021Common Stock · traded 8 January 2021 · filed 12 January 2021
- ▼ sold on the open market 10,500 shares of PTCTSEC Form 412 January 2021Common Stock · traded 8 January 2021 · filed 12 January 2021
- exercised options over 9,278 shares of PTCTSEC Form 412 January 2021Common Stock · traded 8 January 2021 · filed 12 January 2021
- ▼ sold on the open market 9,278 shares of PTCTSEC Form 412 January 2021Common Stock · traded 8 January 2021 · filed 12 January 2021
- was granted 10,800 shares of Ptc TherapeuticsSEC Form 48 January 2021Common Stock · traded 6 January 2021 · filed 8 January 2021
- was granted 63,000 shares of Ptc Therapeutics (a derivative holding)SEC Form 48 January 2021Stock Option (Right to Buy) · traded 6 January 2021 · filed 8 January 2021
- ▼ sold on the open market 112 shares of Ptc TherapeuticsSEC Form 47 January 2021Common Stock · traded 5 January 2021 · filed 7 January 2021
- ▼ sold on the open market 176 shares of Ptc TherapeuticsSEC Form 47 January 2021Common Stock · traded 5 January 2021 · filed 7 January 2021
- ▼ sold on the open market 2,581 shares of Ptc TherapeuticsSEC Form 41 July 2020Common Stock · traded 29 June 2020 · filed 1 July 2020
- was granted 64,250 shares of Ptc Therapeutics (a derivative holding)SEC Form 431 January 2020Stock Option (Right To Buy) · traded 29 January 2020 · filed 31 January 2020
- was granted 9,300 shares of Ptc TherapeuticsSEC Form 431 January 2020Common Stock · traded 29 January 2020 · filed 31 January 2020
- ▼ sold on the open market 330 shares of Ptc TherapeuticsSEC Form 427 January 2020Common Stock · traded 23 January 2020 · filed 27 January 2020
- ▼ sold on the open market 121 shares of Ptc TherapeuticsSEC Form 48 January 2020Common Stock · traded 6 January 2020 · filed 8 January 2020
- ▼ sold on the open market 200 shares of Ptc TherapeuticsSEC Form 48 January 2020Common Stock · traded 6 January 2020 · filed 8 January 2020
- ▼ sold on the open market 63 shares of Ptc TherapeuticsSEC Form 48 January 2020Common Stock · traded 7 January 2020 · filed 8 January 2020
- was granted 50,000 shares of Ptc Therapeutics (a derivative holding)SEC Form 43 June 2019Stock Option (Right To Buy) · traded 31 May 2019 · filed 3 June 2019
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.